Inger L. Meek

Inger L. Meek

Auto-generated profile, based on publicly available information

Inger L. Meek

Arthritis Center Twente, Twente University and Medisch Spectrum Twente, 7500KA Enschede, The Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2010 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
IMInger L. Meek
Inger L. Meek
MLMart A.F.J. Van de Laar
Mart A.F.J. Van de Laar
HVHarald E. Vonkeman
Harald E. Vonkeman
While aspirin may offer protection, other non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) can cause serious cardiovascular side effects and complications. This has led to a general "black box" warning for cardiovascular adverse events for NSAIDs. This review explores the different mechanisms underlying the protective effects of aspirin, the NSAID associated renovascular effects causing hypertension, edema and heart failure, the cardiovascular effects causing myocardial infarction and stroke, and the possible deleterious interaction between NSAIDs and aspirin.

30 July 2012 in Rheumatology
Verified
Journal Article
Open access
PDF file
IMInger L. Meek
Inger L. Meek
HPH. Susan J. Picavet
H. Susan J. Picavet
HVHarald E. Vonkeman
Harald E. Vonkeman
WVW. M. Monique Verschuren
W. M. Monique Verschuren
MLMart A. F. J. van de Laar
Mart A. F. J. van de Laar
Objectives. To study the prevalence of cardiovascular risk factors among patients attending a rheumatology outpatient clinic in comparison with the general population. Methods. Cross-sectional comparison between a rheumatic outpatient cohort of consecutive patients (n = 1233) between 36 and 75 years of age attending the Arthritis Center Twente (ACT) in the year 2009: RA (n = 546), gout (n = 129), OA (n = 168), CTD (n = 85), PMR (n = 91) and chronic localized or generalized pain syndromes (CPSs; n = 214) and a random sample from a long-lasting population-based health study in the Netherlands (n = 4523). The main outcome measures were hypertension (systolic blood pressure ≥ 140 mmHg and/or a diastolic blood pressure ≥ 90 mmHg and/or the use of antihypertensive medication), abnormal cholesterol profile (total cholesterol ≥ 6.5 mmol/l, and/or high-density lipoprotein < 0.9 mmol/l and/or use of lipid lowering medication), overweight (BMI ≥ 25 kg/m2), obesity (BMI ≥ 30 kg/m2) and cigarette smoking habits (self-reported current smoking). Results. Compared with the general population, patients with rheumatic diseases have a significantly higher prevalence of hypertension (PACT = 68%, Pgeneral = 57%), being overweight (PACT = 72%, Pgeneral = 62%), obesity (PACT = 30%, Pgeneral = 17%) and cigarette smoking (PACT = 26%, Pgeneral = 21%). The worst risk profile was found in gout patients, with higher prevalence of all cardiovascular risk factors studied. Conclusion. Lifestyle-associated potentially modifiable cardiovascular risk factors are over-represented along the whole spectrum of chronic rheumatic diseases, and not only in RA, as suggested by preceding studies.